WSJ Prime7.00%▲ 25 bpsSOFR3.87%▲ 23 bpsFed Funds Target4.00%▲ 25 bps10-Yr Treasury5.28%▲ 50 bpsDiesel, retail$6.199▲ 60¢Bank C&I Lending$2,935B▲ 1.62%WSJ Prime7.00%▲ 25 bpsSOFR3.87%▲ 23 bpsFed Funds Target4.00%▲ 25 bps10-Yr Treasury5.28%▲ 50 bpsDiesel, retail$6.199▲ 60¢Bank C&I Lending$2,935B▲ 1.62%

Front Page › Markets & Main Street › From Wall Street

Market Calls, Investigated

Monro (MNRO) as a Takeover Candidate: Icahn's Stake, Mavis, and a Poison Pill That Expires November 6, 2026

Monro, the auto repair and tire chain, has become a takeover bet. A small-cap fund says Mavis could be a credible buyer and expects strategic news after Carl Icahn's buildup. SEC filings show a smaller Icahn stake than claimed, and a poison pill that expires November 6, 2026.

Car tires wrapped in heavy iron chains sit near an amber medicine vial and a lug wrench on a metal workbench.
Market Calls, Investigated · Markets & Main Street

Monro, Inc. (Nasdaq: MNRO), a 1,115-store auto repair and tire chain, is being pitched as a takeover candidate. Kingdom Capital, a small-cap fund, says Mavis Tire Express could be a credible acquirer and expects strategic news after Carl Icahn's buildup in Monro stock. The nearest hard date is November 6, 2026, when Monro's shareholder rights plan expires.

This is journalism and commentary, not investment advice. We hold no position unless stated.

Key facts

  • Ticker and exchange: Monro, Inc., MNRO, Nasdaq.
  • Situation type: Potential takeover candidate; no deal or bid has been announced.
  • The call: Kingdom Capital (@kingdomcapadv) is long Monro and named Mavis as a possible buyer on October 5, 2026.
  • Icahn stake: Icahn Enterprises reported 5,078,573 Monro shares, or 16.92%, in its latest Schedule 13D amendment on November 7, 2025.
  • Price: Monro closed at $13.74 on October 8, 2026, versus $13.64 on October 5, 2026, the last close before the call.
  • Catalyst date: Monro's rights plan, which caps any holder at 17.5%, expires on November 6, 2026.
  • Main risk: No buyer appears and Monro's shrinking sales keep pressure on the stock.

Is Monro a good bet right now?

That depends on whether a buyer shows up. Monro has not announced a sale process in the SEC filings we reviewed.

At $13.74, Monro trades well below the $17.23 to $17.48 per share Icahn paid for his last purchases in October 2025. Monro pays a quarterly dividend of $0.28 per share, about an 8.2% annual yield at that price.

Why are investors bullish on Monro?

  • A fresh comparable deal. Mavis completed its purchase of Pep Boys from Icahn Enterprises for about $700 million in cash on August 20, 2026, per the closing announcement. Mavis now has more than 4,400 locations.
  • Large holders. Icahn holds 16.92%, and Gabelli entities reported about 10.7% combined in an April 27, 2026 amendment.
  • Fewer obstacles. Monro's Class C convertible preferred stock, held by a group including director Peter Solomon, converted into 1,204,908 common shares on June 18, 2026, eliminating that share class, per the 10-Q.
  • The pill ends soon. The rights plan adopted on November 9, 2025 runs for one year and expires on November 6, 2026.

Who's making this call and why?

Kingdom Capital is the X account of Kingdom Capital Advisors, a small-cap value manager with about 12,500 followers that publishes quarterly fund letters.

Replying to a Wall Street Journal post about Mavis, the account wrote that Mavis "Seems like a credible acquirer of $MNRO if they want to grow to 10k units".

The firm's Q3 2026 letter, signed by Chief Investment Officer David Bastian, says it bought Monro. It expects "potential strategic news soon from Monro (MNRO)" because Icahn accumulated "a third of the outstanding shares" at prices above Kingdom's cost.

A fact check. SEC filings do not show a one-third Icahn stake. Icahn's last amendment reports 16.92%. By our arithmetic, that is about 16.2% of the 31,264,060 shares outstanding on June 27, 2026. Icahn plus Gabelli together come to roughly 27%.

Track record. In our tracking of Kingdom Capital's public calls, the account is 4-14 (a .222 win rate) on 18 calls scored at 180 days against the S&P 500, with an average edge of -17.3 percentage points. That record does not predict how the Monro call will turn out.

Other supporters:

Who disagrees?

The bear case in numbers:

  • First-quarter fiscal 2027 sales fell 4.6% to $287.1 million, and comparable store sales fell 1.7%, per Monro's July 29, 2026 results.
  • Adjusted operating income dropped to $2.2 million from $14.0 million a year earlier.
  • Store-count math from Pep Boys may not transfer, because Icahn kept Pep Boys' owned real estate out of that sale.

What are the key facts to verify?

  • Icahn's initial 13D reported 4,439,914 shares bought for about $84.7 million, and lists proposing a sale or merger among possible actions.
  • Icahn's November 7, 2025 amendment raised the stake to 5,078,573 shares.
  • Monro's rights plan 8-K sets the 17.5% trigger, which blocks Icahn from buying much more before the plan expires.
  • Monro had 1,115 company-operated stores and 46 Car-X franchised locations on June 27, 2026.

What would prove it right or wrong?

Signals the call is working:

  • Monro announces a strategic review, a sale agreement, or a bid from Mavis or another buyer.
  • Icahn files a new 13D amendment after the rights plan expires.
  • Monro lets the rights plan lapse on November 6, 2026 without renewing it.

Signals it is failing:

  • Monro extends the rights plan or adopts a new one.
  • Comparable store sales keep falling and the dividend is cut.
  • Monro trades toward $10 with no buyer in sight.

This is journalism and commentary, not investment advice. We hold no position unless stated.

Questions readers actually ask

What does Monro, Inc. do?

Monro, Inc. (Nasdaq: MNRO) provides automotive undercar repair, tire sales and tire services in the United States. Monro had 1,115 company-operated stores in 32 states and 46 Car-X franchised locations as of June 27, 2026.

What is the takeover call on Monro stock?

Kingdom Capital (@kingdomcapadv) is long Monro (MNRO) and wrote on October 5, 2026 that Mavis looks like a credible acquirer of Monro. Its Q3 2026 fund letter says it expects potential strategic news soon from Monro after Carl Icahn's buildup in the stock.

How much of Monro does Carl Icahn own?

Icahn Enterprises reported 5,078,573 Monro (MNRO) shares, or 16.92%, in a Schedule 13D amendment filed November 7, 2025, and has filed no later amendment. Claims on X and in Kingdom Capital's letter that Icahn owns about a third of Monro are not supported by those SEC filings.

When does Monro's poison pill expire?

Monro's shareholder rights plan, adopted November 9, 2025, expires on November 6, 2026. The plan is triggered if a holder acquires 17.5% or more of Monro (MNRO) stock, which limits how much more Icahn can buy before then.

Why is Mavis seen as a possible buyer of Monro?

Mavis completed its purchase of Pep Boys from Icahn Enterprises for about $700 million in cash on August 20, 2026, bringing its network to more than 4,400 locations. Bulls argue Monro (MNRO), with 1,115 stores, would fit the same roll-up strategy, though no bid has been announced.

What is Kingdom Capital's track record on stock calls?

In our tracking of public calls, Kingdom Capital is 4-14, a .222 win rate, on 18 calls scored at 180 days against the S&P 500, with an average edge of -17.3 percentage points. That record does not predict how the Monro (MNRO) call will turn out.

What is the bear case for Monro stock?

Monro (MNRO) first-quarter fiscal 2027 sales fell 4.6% to $287.1 million, comparable store sales fell 1.7%, and adjusted operating income dropped to $2.2 million from $14.0 million. AdvisorShares disclosed Monro as a short position in its HDGE bear ETF, and even one Monro bull on X sees about $10 if no deal happens.

What are the key numbers for Monro as of October 2026?

Monro (MNRO) closed at $13.74 on October 8, 2026, and pays a quarterly dividend of $0.28 per share, about an 8.2% yield at that price. Icahn's last purchases in October 2025 were at $17.23 to $17.48 per share.

Is Monro a good bet right now?

The case for Monro (MNRO) is a possible sale after the rights plan expires, with Icahn and Gabelli holding about 27% combined and a recent Pep Boys deal as a price reference. The case against is declining sales, no announced sale process and a downside if no buyer emerges, so the outcome is uncertain and this is not a recommendation.

What would prove the Monro takeover call right or wrong?

A strategic review, a bid from Mavis or another buyer, or the rights plan lapsing on November 6, 2026 would support the Monro (MNRO) call. A renewed poison pill, a dividend cut or continued comparable sales declines with no buyer would point the other way.

More from Market Calls, Investigated

The series →

LuxExperience (LUXE): Can the Net-a-Porter Turnaround Push the Stock Out of Its $10 Range?

From Wall Street · Oct 9

Cricut (CRCT): A Fund Manager Says $20.3 Million of Tariff Refunds Flattered Earnings

From Wall Street · Oct 9

Bunge (BG): A Short Seller Flags Executive Exits After the $10.6 Billion Viterra Deal

From Wall Street · Oct 9

More in Markets & Main Street

All →

SoundThinking (SSTI) Buyout: $8 Cash Plus a $3 CVR, and the 2027 Revenue Bet Hidden in the Spread

From Wall Street · Oct 9

Arqit Quantum (ARQQ): A Short Seller Says This Quantum Stock Trades at 450 Times Revenue

From Wall Street · Oct 9

Nova Minerals (NVA): A Short Seller Targets the Antimony Story After a Going-Concern Warning

From Wall Street · Oct 9

Getting the calls? Shut it down.

MCAFax was built to do the thing you can't do from inside the room: make the phone stop. Check any broker against our member-built database, send cease & desist letters from your own Gmail, and build the paper trail. Some laws, like the TCPA, put statutory damages on illegal calls — whether they apply to your calls depends on your situation, and business lines get less protection than home ones. It's free, and we're not a law firm.

Join the network